Durham biotech company raises $70 million
July 09, 2021 at 07:53 AM EDT
A Duke University spinout raised the money to further develop its technology to predict therapeutic responses in cancer patients and aid drug development.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|